TrialLeukemia2018

Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial.

S Ailawadhi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.